Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Hoerter Steven L.
Relationship:  
City:   Boulder
State:   CO
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   83,704    

Indirect Shares

  0      
Direct Value   $2,228,260    

Indirect Value

  $0      
Total Shares   83,704      
Total Value   $2,228,260      


Agios Pharmaceuticals Inc
 $375,714 Deciphera Pharmaceuticals, Inc.
 $1,852,546 Agios Pharmaceuticals Inc
 $375,714 Deciphera Pharmaceuticals, Inc.
 $1,852,546
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    2    

     Stock price went up :

    0   
    2    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   2.0   
     Percentage Gain/Loss :
     0.0%
 172.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Clovis Oncology, Inc. CLVS See Remarks 2015-03-05 0 2013-06-04 0    Premium*  
            Agios Pharmaceuticals Inc AGIO Chief Commercial Officer 2019-03-04 10,941 2018-01-23 0    Premium*  
            Deciphera Pharmaceuticals, Inc. DCPH 2023-12-13 72,763 2019-03-18 0    Premium*  
* Premium Members only  

Records found :    51         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
CLVS Clovis Oncology, Inc. See Remarks   •       –      –    2013-06-04 4 S $73.06 $730,600 D/D (10,000) 0 0 -
CLVS Clovis Oncology, Inc. See Remarks   •       –      –    2015-01-13 4 AS $62.00 $620,000 D/D (10,000) 0 0 -
CLVS Clovis Oncology, Inc. See Remarks   •       –      –    2015-01-16 4 AS $67.00 $670,000 D/D (10,000) 0 0 -
CLVS Clovis Oncology, Inc. See Remarks   •       –      –    2015-02-17 4 AS $72.00 $720,000 D/D (10,000) 0 0 -
CLVS Clovis Oncology, Inc. See Remarks   •       –      –    2015-03-05 4 AS $80.00 $1,600,000 D/D (20,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Commercial Officer   •       –      –    2018-01-23 4 AS $74.83 $1,870,750 D/D (25,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Commercial Officer   •       –      –    2018-02-22 4 AS $78.63 $161,192 D/D (2,050) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Commercial Officer   •       –      –    2018-03-22 4 AS $84.65 $173,533 D/D (2,050) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Commercial Officer   •       –      –    2018-04-23 4 AS $85.95 $176,198 D/D (2,050) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Commercial Officer   •       –      –    2018-05-23 4 AS $85.76 $175,808 D/D (2,050) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Commercial Officer   •       –      –    2018-06-22 4 AS $97.58 $200,039 D/D (2,050) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Commercial Officer   •       –      –    2018-07-25 4 AS $84.58 $173,389 D/D (2,050) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Commercial Officer   •       –      –    2018-08-24 4 AS $74.92 $153,586 D/D (2,050) 0 0 -
DCPH Deciphera Pharmaceuticals... President and CEO   •       •      –    2023-03-21 4 AS $15.57 $116,782 D/D (7,500) 0 0 %
AGIO Agios Pharmaceuticals Inc Chief Commercial Officer   •       –      –    2018-02-22 4 OE $39.76 $81,508 D/D 2,050 2,050 0 -
AGIO Agios Pharmaceuticals Inc Chief Commercial Officer   •       –      –    2018-03-22 4 OE $39.76 $81,508 D/D 2,050 2,050 0 -
AGIO Agios Pharmaceuticals Inc Chief Commercial Officer   •       –      –    2018-04-23 4 OE $39.76 $81,508 D/D 2,050 2,050 0 -
AGIO Agios Pharmaceuticals Inc Chief Commercial Officer   •       –      –    2018-05-23 4 OE $39.76 $81,508 D/D 2,050 2,050 0 -
AGIO Agios Pharmaceuticals Inc Chief Commercial Officer   •       –      –    2018-06-22 4 OE $39.76 $81,508 D/D 2,050 2,050 0 -
AGIO Agios Pharmaceuticals Inc Chief Commercial Officer   •       –      –    2018-07-25 4 OE $39.76 $81,508 D/D 2,050 2,050 0 -
AGIO Agios Pharmaceuticals Inc Chief Commercial Officer   •       –      –    2018-08-24 4 OE $39.76 $81,508 D/D 2,050 2,050 0 -
DCPH Deciphera Pharmaceuticals... President and CEO   •       •      –    2023-02-14 4 AS $16.00 $480,720 D/D (30,045) 7,500 0 %
AGIO Agios Pharmaceuticals Inc Chief Commercial Officer   •       –      –    2019-01-22 4 D $52.82 $304,719 D/D (5,769) 9,231 0 -
CLVS Clovis Oncology, Inc. See Remarks   •       –      –    2013-06-04 4 OE $11.02 $110,200 D/D 10,000 10,000 0 -
CLVS Clovis Oncology, Inc. See Remarks   •       –      –    2015-01-13 4 OE $11.02 $110,200 D/D 10,000 10,000 0 -

  51  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed